Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

When preparing a 510(k) for a device that introduces new technological features compared to its predicate—such as an orthopedic implant with a novel surface coating or a diagnostic software with a new...

💬 1 👁️ 8 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

When preparing a 510(k) submission for a Class II device that incorporates an incremental but significant technological change, such as an orthopedic implant with a novel surface material designed to ...

💬 1 👁️ 29 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

For manufacturers of a 510(k)-cleared device, the decision between documenting a modification with a 'Letter to File' versus submitting a new 510(k) is a recurring challenge. Beyond the foundational r...

💬 1 👁️ 32 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

For a medical device company, particularly a startup, successfully navigating the FDA’s Small Business Determination (SBD) process is a critical step to manage costs associated with MDUFA user fees. S...

💬 1 👁️ 22 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

When preparing a 510(k) submission for a device with technological differences from its predicate—such as an electrosurgical generator featuring a modified energy delivery algorithm and a new user int...

💬 1 ✓ 👁️ 34 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

When pursuing a 510(k) submission using a 'split predicate' approach—combining key features from two or more legally marketed devices—how can a sponsor construct a robust substantial equivalence argum...

💬 1 ✓ 👁️ 17 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

For a sponsor preparing a 510(k) for a Class II device, such as a software-enabled cardiac monitor or an integrated continuous glucose monitoring system (iCGM) under 21 CFR 862.1355, a critical challe...

💬 1 ✓ 👁️ 27 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

When preparing a 510(k) for a connected medical device, such as a networked patient monitor or a cloud-based SaMD, how can sponsors develop a cybersecurity documentation package that forms a cohesive,...

💬 1 👁️ 21 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

When a sponsor receives a hold on their 510(k) submission, how can they distinguish between a Refuse to Accept (RTA) hold and an Additional Information (AI) request, and what are the critical differen...

💬 1 👁️ 28 👍 0
Asked: 2 months ago
Asked by Lo H. Khamis

For manufacturers of 510(k)-exempt Class I devices, such as elastic bandages or tongue depressors, the term "General Controls" can be misleadingly simple. While these devices do not require premarket ...

💬 1 ✓ 👁️ 25 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

For a Class II medical device with clear technological differences from its chosen predicate—such as an orthopedic implant with a novel biocompatible coating or an infusion pump with significant softw...

💬 1 👁️ 59 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

When preparing a 510(k) submission for a device with technological differences from its predicate—such as an infusion pump incorporating a new user interface and different patient-contacting materials...

💬 1 👁️ 16 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

When developing a combination product, such as an antimicrobial-coated catheter or a pre-filled injector pen, how should a sponsor definitively determine the product's Primary Mode of Action (PMOA) to...

💬 1 ✓ 👁️ 16 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis

When a sponsor develops a novel medical device by creating a hybrid system—for example, an electrosurgical device that combines a unique energy waveform from Predicate A with an advanced tissue-monito...

💬 1 ✓ 👁️ 23 👍 1
Asked: 2 months ago
Asked by Lo H. Khamis

For a company developing a digital health product, such as a wearable sensor that analyzes sleep data, what is a robust analytical framework for determining whether the product is a regulated medical ...

💬 1 👁️ 52 👍 2
Asked: 2 months ago
Asked by Lo H. Khamis
Showing page 34 of 42 (830 total questions)